Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alacare PDT for Actinic Keratosis on Upper Extremities
NCT03606122Phase 2Completed
- Sponsor
- photonamic GmbH & Co. KG
- Start
- Jul 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 5-aminolevulinic acid in actinic keratosis (AK), sponsored by photonamic GmbH & Co. KG. Primary endpoint: Clinical Activity (Clearance) at 12 weeks. Started Jul 2018; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT03606122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03606122.